RxDoctor Payments Data

Tobias Kohler, MD

Urology · Rochester, MNNPI 1073656617

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Coloplast accounts for 96.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $47,732 and has fallen 91.8% since, to $3,924 in 2024. Among urology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$88,996in general payments, 2019–2025

Across 126 payments — averaging $706.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$86K
  • Boston Scientific$2K
  • Axonics, Inc.$347
  • Cook Medical LLC$200
  • SRS Medical Systems, Inc.$96
  • Astellas Pharma US Inc$75
  • plus $137 from 3 others
$24,150in research payments, 2019–2025

Across 5 payments — averaging $4829.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo USA, Inc.$17K
  • Endo Pharmaceuticals Inc.$5K
  • AbbVie$2K
  • Boston Scientific$465

What the payments were for

  • Consulting fees$46,94153%
  • Speaking & faculty fees$1,0001%
  • Travel & lodging$28,97433%
  • Food & beverage$4,8795%
  • Education$7,2028%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$88,996 in reported general payments places this provider in the 95th percentile of 247 urology providers in Minnesota.

See all urology providers in Minnesota

Medicare billing

Part B allowed, 2024
$222,617
Medicare patients
330
Services billed
2,395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dutasteride11$509

Paid to pharmacies, not to this prescriber.

Other urology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →